Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed
- PMID: 2137665
- DOI: 10.1016/0002-9149(90)90807-d
Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed
Abstract
Left ventricular (LV) hypertrophy has been repeatedly shown to be associated with a marked increase in mortality risk. Available data, however, do not provide evidence that the risk associated with the increase in cardiac muscle mass is independent of the severity of preexistent coronary artery disease. In a cohort of predominantly black patients with a high prevalence of hypertension and LV hypertrophy, LV mass as estimated by echocardiography was found to be a powerful prognostic factor independent of ejection fraction and obstructive coronary disease. After excluding patients with either a dilated LV cavity (diastolic internal diameter greater than 5.8 cm) or asymmetric septal hypertrophy (septal:posterior wall ratio greater than 1.5) LV mass/height remained significantly increased in decedents compared to survivors (116 +/- 38 vs 131 +/- 47 g/m, p = 0.014), while the thickness of the ventricular septum and the posterior wall were even more highly predictive of a fatal outcome (p = 0.003 and 0.001, respectively). After exclusion of patients with eccentric LV hypertrophy, differences in LV muscle mass in survivors and decedents were due entirely to increased thickness of the ventricular wall, and no differences in cavity dimensions or LV ejection fraction were noted. Stepwise regression analysis was used to demonstrate that measures of LV hypertrophy were the most important predictors of survival and eliminated the contribution of all other prognostic factors to the model except the number of stenotic vessels. The relative risk associated with a 100-g increase in mass was 2.1, while a 0.1-cm increase in posterior wall thickness was associated with approximately a 7-fold increase in the risk of dying.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.J Am Coll Cardiol. 1998 Jun;31(7):1635-40. doi: 10.1016/s0735-1097(98)00131-4. J Am Coll Cardiol. 1998. PMID: 9626845
-
The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults.JAMA. 1995 May 24-31;273(20):1592-7. JAMA. 1995. PMID: 7745772
-
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.Am J Cardiol. 1996 Jul 15;78(2):197-202. doi: 10.1016/s0002-9149(96)90395-1. Am J Cardiol. 1996. PMID: 8712142
-
Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy.J Hypertens. 2005 Jan;23(1):183-91. doi: 10.1097/00004872-200501000-00029. J Hypertens. 2005. PMID: 15643141
-
Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences.Hypertens Res. 1999 Mar;22(1):1-9. doi: 10.1291/hypres.22.1. Hypertens Res. 1999. PMID: 10221344 Review.
Cited by
-
Pathoanatomic Findings Associated With Duty-Related Cardiac Death in US Firefighters: A Case-Control Study.J Am Heart Assoc. 2018 Sep 18;7(18):e009446. doi: 10.1161/JAHA.118.009446. J Am Heart Assoc. 2018. PMID: 30371185 Free PMC article.
-
Regression of left ventricular hypertrophy: are there preferred drugs?Curr Hypertens Rep. 2003 Oct;5(5):368-71. doi: 10.1007/s11906-003-0081-2. Curr Hypertens Rep. 2003. PMID: 12948428 Review.
-
PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.PLoS One. 2014 Jul 11;9(7):e102148. doi: 10.1371/journal.pone.0102148. eCollection 2014. PLoS One. 2014. PMID: 25014216 Free PMC article.
-
Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study.BMC Cardiovasc Disord. 2017 Aug 23;17(1):229. doi: 10.1186/s12872-017-0663-6. BMC Cardiovasc Disord. 2017. PMID: 28835229 Free PMC article. Clinical Trial.
-
Effects of isolated obesity on systolic and diastolic left ventricular function.Heart. 2003 Oct;89(10):1152-6. doi: 10.1136/heart.89.10.1152. Heart. 2003. PMID: 12975404 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical